Endometrial hyperplasia other diagnostic studies

Jump to navigation Jump to search

Endometrial hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Case Studies

Case #1

Endometrial hyperplasia other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial hyperplasia other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial hyperplasia other diagnostic studies

CDC on Endometrial hyperplasia other diagnostic studies

Endometrial hyperplasia other diagnostic studies in the news

Blogs on Endometrial hyperplasia other diagnostic studies

Directions to Hospitals Treating Endometrial hyperplasia

Risk calculators and risk factors for Endometrial hyperplasia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]

Overview

Hysteroscopy may be helpful in the direct visualization of precancerous lesions.[1] Diagnosis of endometrial hyperplasia is usually performed through curettage of the uterine cavity to obtain endometrial tissue for histopathologic analysis.[2]

Other Diagnostic Studies

Hysteroscopy

  • Hysteroscopy may be helpful in the direct visualization of precancerous lesions.[1]
  • A histopathology sample including any discrete lesions along with the surrounding normal endometrium may be helpful in the diagnosis of precancerous lesions.[1]

D&C

  • Diagnosis of endometrial hyperplasia is usually performed through curettage of the uterine cavity to obtain endometrial tissue for histopathologic analysis.[2]

Flowchart

  • The following flow-chart shows a decision algorithm for the management of symptomatic postmenopausal women with endometrial thickness > 4 mm:[3]

References

  1. 1.0 1.1 1.2 Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M; et al. (2012). "Management of endometrial precancers". Obstet Gynecol. 120 (5): 1160–75. doi:http://10.1097/AOG.0b013e31826bb121 Check |doi= value (help). PMC 3800154. PMID 23090535.
  2. 2.0 2.1 Bobrowska K, Pietrzak B, Jabiry-Zieniewicz Z, Cyganek A, Kaminski P, Wielgos M; et al. (2007). "Operative treatment of endometrial hyperplasia in kidney graft recipients: report of seven cases". Transplant Proc. 39 (9): 2756–8. doi:10.1016/j.transproceed.2007.09.023. PMID 18021979.
  3. 3.0 3.1 Giannella L, Mfuta K, Setti T, Cerami LB, Bergamini E, Boselli F (2014). "A risk-scoring model for the prediction of endometrial cancer among symptomatic postmenopausal women with endometrial thickness > 4 mm". Biomed Res Int. 2014: 130569. doi:10.1155/2014/130569. PMC 4065750. PMID 24991535.

Template:WikiDoc Sources